Alessandra De Feo

697 total citations
18 papers, 529 citations indexed

About

Alessandra De Feo is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alessandra De Feo has authored 18 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alessandra De Feo's work include MicroRNA in disease regulation (7 papers), RNA Research and Splicing (7 papers) and Extracellular vesicles in disease (5 papers). Alessandra De Feo is often cited by papers focused on MicroRNA in disease regulation (7 papers), RNA Research and Splicing (7 papers) and Extracellular vesicles in disease (5 papers). Alessandra De Feo collaborates with scholars based in Italy, United States and Spain. Alessandra De Feo's co-authors include Alessandra Carè, Federica Felicetti, Rossella Puglisi, Maria Bellenghi, Maria Cristina Errico, Gianfranco Mattia, Francesca Pedini, Luca Pasquini, Giada Pontecorvi and Elena Pagani and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Alessandra De Feo

17 papers receiving 526 citations

Peers

Countries citing papers authored by Alessandra De Feo

Since Specialization

Citations

This map shows the geographic impact of Alessandra De Feo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra De Feo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra De Feo more than expected).

Fields of papers citing papers by Alessandra De Feo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra De Feo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra De Feo. The network helps show where Alessandra De Feo may publish in the future.

Co-authorship network of co-authors of Alessandra De Feo

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra De Feo. A scholar is included among the top collaborators of Alessandra De Feo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra De Feo. Alessandra De Feo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions 2024 ·Biomolecules ·(unknown), Alessandra De Feo, Katia Scotlandi	0
2	CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles 2024 ·International Journal of Molecular Sciences ·Alessandra De Feo, Marcello Manfredi, Caterina Mancarella, (unknown), Veronica De Giorgis, Ymera Pignochino, Marika Sciandra, (unknown), Massimo Donadelli, Katia Scotlandi	3
3	CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1‐targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape 2024 ·Journal of Cell Communication and Signaling ·Michela Pasello, Maria Antonella Laginestra, Maria Cristina Manara, Lorena Landuzzi, (unknown), (unknown), (unknown), Alessandra De Feo, Pier‐Luigi Lollini, Katia Scotlandi	1
4	Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages 2023 ·Cancer Immunology Research ·Maria Cristina Manara, Cristina Manferdini, (unknown), (unknown), Spartaco Santi, Alessandra De Feo, (unknown), Michela Pasello, Lorena Landuzzi, Pier‐Luigi Lollini, Francesca Salamanna, Sabrina Dominici, (unknown), Mauro Magnani, Gina Lisignoli, Katia Scotlandi	6
5	Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells 2023 ·Cancer Gene Therapy ·Caterina Mancarella, (unknown), (unknown), Maria Antonella Laginestra, Alessandro Parra, (unknown), G Giordano, Laura Roncuzzi, Manuela Piazzi, William L. Blalock, Marta Columbaro, Alessandra De Feo, Katia Scotlandi	6
6	Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response 2022 ·Frontiers in Endocrinology ·(unknown), Maria Cristina Manara, Sérgio Valente, (unknown), Alberto Bavelloni, Alessandra De Feo, William L. Blalock, Elisabetta Di Bello, David Piñeyro, Angelika Merkel, Manel Esteller, Òscar M. Tirado, Antonello Mai, Katia Scotlandi	9
7	miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness 2022 ·Cancers ·Alessandra De Feo, Laura Pazzaglia, (unknown), (unknown), Michela Pasello, (unknown), (unknown), Cristina Ferrari, Giuseppe Bianchi, (unknown), Katia Scotlandi	7
8	Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma 2021 ·Cancer Research ·(unknown), Maria Antonella Laginestra, (unknown), Caterina Mancarella, Lorena Landuzzi, Alessandro Parra, (unknown), (unknown), Alessandra De Feo, (unknown), Michela Pasello, Alberto Righi, Pier‐Luigi Lollini, Emanuela Palmerini, Davide María Donati, Maria Cristina Manara, Katia Scotlandi	16
9	Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma 2020 ·Journal of Cell Communication and Signaling ·Marika Sciandra, Alessandra De Feo, Alessandro Parra, Lorena Landuzzi, Pier‐Luigi Lollini, Maria Cristina Manara, Gianfranco Mattia, Giada Pontecorvi, Cristina Baricordi, Clara Guerzoni, Alberto Bazzocchi, Alessandra Longhi, Katia Scotlandi	8
10	Sex and Gender Disparities in Melanoma 2020 ·Cancers ·Maria Bellenghi, Rossella Puglisi, Giada Pontecorvi, Alessandra De Feo, Alessandra Carè, Gianfranco Mattia	90
11	Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation 2019 ·Cell Death and Disease ·Alessandra De Feo, Marika Sciandra, Manuela Ferracin, Federica Felicetti, Annalisa Astolfi, Ymera Pignochino, Piero Picci, Alessandra Carè, Katia Scotlandi	29
12	Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cells 2017 ·SHILAP Revista de lepidopterología ·Benedetto Sacchetti, Alessandro Fatica, (unknown), Antonio Sorrentino, Michele Signore, (unknown), Federica Felicetti, Alessandra De Feo, Elvira Pelosi, Alessandra Carè, Edoardo Pescarmona, Jan O. Gordeladze, M Valtieri	10
13	Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma 2016 ·Journal of Translational Medicine ·Federica Felicetti, Alessandra De Feo, Carolina Coscia, Rossella Puglisi, Francesca Pedini, Luca Pasquini, Maria Bellenghi, Maria Cristina Errico, Elena Pagani, Alessandra Carè	144
14	CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling 2015 ·Oncogene ·Selena Ventura, D N T Aryee, Federica Felicetti, Alessandra De Feo, Caterina Mancarella, Maria Cristina Manara, Piero Picci, Mario P. Colombo, Heinrich Kovar, Alessandra Carè, Katia Scotlandi	55
15	AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression 2015 ·Oncogene ·Nadia Felli, Maria Cristina Errico, Francesca Pedini, Marina Petrini, Rossella Puglisi, Maria Bellenghi, Alessandra Boe, Federica Felicetti, Gianfranco Mattia, Alessandra De Feo, Lisabianca Bottero, Claudio Tripodo, Alessandra Carè	17
16	SCD5‐induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B 2015 ·The Journal of Pathology ·Maria Bellenghi, Rossella Puglisi, Francesca Pedini, Alessandra De Feo, Federica Felicetti, Lisabianca Bottero, Sabina Sangaletti, Maria Cristina Errico, Marina Petrini, (unknown), (unknown), Nadia Felli, Luca Pasquini, Claudio Tripodo, Mario P. Colombo, Alessandra Carè, Gianfranco Mattia	32
17	HOXB1 restored expression promotes apoptosis and differentiation in the HL60 leukemic cell line 2013 ·Cancer Cell International ·Marina Petrini, Federica Felicetti, Lisabianca Bottero, Maria Cristina Errico, Ornella Morsilli, Alessandra Boe, Alessandra De Feo, Alessandra Carè	17
18	miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 2013 ·PLoS ONE ·Nadia Felli, Federica Felicetti, (unknown), Maria Cristina Errico, Lisabianca Bottero, Alessio Cannistraci, Alessandra De Feo, Marina Petrini, Francesca Pedini, Mauro Biffoni, Ester Alvino, Massimo Negrini, Manuela Ferracin, Gianfranco Mattia, Alessandra Carè	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact